ASTRO: Brachytherapy Enough for Mid-Risk Prostate Cancer (CME/CE)

(MedPage Today) -- Similar outcomes, fewer side effects vs external beam therapy
via ASTRO: Brachytherapy Enough for Mid-Risk Prostate Cancer (CME/CE)
by